- eHealth software solutions company Respiri (RSH) has secured a product referral agreement with the Australian Patients Association (APA)
- The APA is an independent charity that supports around 1.1 million Australian patients and protects their rights and interests
- Under the agreement, the APA will provide patient referrals to Respiri once its wheezo device is launched in October
- In exchange, Respiri will pay the APA a small commission on device sales
- This deal follows the recently announced partnership between Respiri and the APA to support patients living with asthma through Respiri’s wheezo experiential program
- Company shares are up 3.23 per cent and are trading for 16 cents
eHealth software solutions company Respiri (RSH) has secured a product referral agreement with the Australian Patients Association (APA).
The APA is an independent charity that supports Australian patients and protects their rights and interests. The APA is connected with 1.1 million Australian patients and 15,000 healthcare practitioners.
The agreement follows a recently announced partnership between Respiri and the APA to support patients living with asthma through Respiri’s wheezo experiential program.
The experiential program is a real-world asthma management study designed to support patients living with asthma. Asthma reportedly affects roughly 11 per cent of all Australians.
“We are delighted to have extended our productive relationship with the APA beyond our patient Experiential Program to a commercial agreement that seeks to educate and build awareness of the benefits of wheezo to APA’s extensive patient network within Australia,” Respiri CEO and Managing Director Marjan Mikel said.
Under the product referral agreement, the APA will utilise its customer network, database and referral codes to provide patient referrals to Respiri once wheezo is launched in October. In exchange, Respiri will pay the APA a small commission on device sales.
Company shares are up 3.23 per cent and are trading for 16 cents each at 12:45 pm AEST.